2016 Q3 Form 10-K Financial Statement

#000143774917000589 Filed on January 12, 2017

View on sec.gov

Income Statement

Concept 2016 Q3 2016 2015 Q3
Revenue -$20.00K $60.00K $20.00K
YoY Change -200.0% -57.14% -33.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $210.0K $1.189M $810.0K
YoY Change -74.07% -38.92% -17.35%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $14.96K $0.00
YoY Change 574.61%
% of Gross Profit
Operating Expenses $1.110M $1.189M $810.0K
YoY Change 37.04% -38.92% -19.0%
Operating Profit -$1.129M
YoY Change -37.51%
Interest Expense -$50.00K $162.8K $0.00
YoY Change 122.46% -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.170M -$2.211M -$800.0K
YoY Change 46.25% 27.84% -14.89%
Income Tax
% Of Pretax Income
Net Earnings -$1.170M -$2.211M -$800.0K
YoY Change 46.25% 27.84% -14.89%
Net Earnings / Revenue -3684.61% -4000.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$62.87K -$129.8K -$48.11K
COMMON SHARES
Basic Shares Outstanding 17.03M
Diluted Shares Outstanding 17.03M

Balance Sheet

Concept 2016 Q3 2016 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $20.00 $200.0K
YoY Change -100.0% -99.99% -25.93%
Cash & Equivalents $24.00 $20.00 $201.4K
Short-Term Investments
Other Short-Term Assets $260.0K $259.1K $2.290M
YoY Change -88.65% -88.67% 1.33%
Inventory
Prepaid Expenses $11.73K $35.76K
Receivables
Other Receivables
Total Short-Term Assets $261.6K $261.7K $2.694M
YoY Change -90.29% -89.51% 6.48%
LONG-TERM ASSETS
Property, Plant & Equipment $5.276K $5.280K $6.399K
YoY Change -17.55% -17.5% -14.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.180M $3.179M $200.0K
YoY Change 1490.0% 1465.12%
Total Long-Term Assets $4.049M $4.049M $1.301M
YoY Change 211.21% 169.74% 28.81%
TOTAL ASSETS
Total Short-Term Assets $261.6K $261.7K $2.694M
Total Long-Term Assets $4.049M $4.049M $1.301M
Total Assets $4.310M $4.310M $3.995M
YoY Change 7.9% 7.9% 12.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $390.0K $385.4K $90.00K
YoY Change 333.33% 351.79% 200.0%
Accrued Expenses $120.0K $118.8K $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $1.160M $1.158M $900.0K
YoY Change 28.89% 28.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.677M $1.677M $997.0K
YoY Change 68.21% 68.21% 1324.31%
LONG-TERM LIABILITIES
Long-Term Debt $2.020M $2.024M $1.680M
YoY Change 20.24% 20.29% 102.41%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.020M $2.024M $1.680M
YoY Change 20.24% 20.29% 102.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.677M $1.677M $997.0K
Total Long-Term Liabilities $2.020M $2.024M $1.680M
Total Liabilities $3.701M $3.701M $2.680M
YoY Change 38.12% 38.12% 197.76%
SHAREHOLDERS EQUITY
Retained Earnings -$5.905M -$3.694M
YoY Change 59.84%
Common Stock $1.703K $1.663K
YoY Change 2.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $609.0K $609.0K $1.315M
YoY Change
Total Liabilities & Shareholders Equity $4.310M $4.310M $3.995M
YoY Change 7.9% 7.9% 12.85%

Cashflow Statement

Concept 2016 Q3 2016 2015 Q3
OPERATING ACTIVITIES
Net Income -$1.170M -$2.211M -$800.0K
YoY Change 46.25% 27.84% -14.89%
Depreciation, Depletion And Amortization $0.00 $14.96K $0.00
YoY Change 574.61%
Cash From Operating Activities $10.00K -$600.9K -$220.0K
YoY Change -104.55% -24.18% 10.0%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K -$725.0K -$100.0K
YoY Change 100.0% 200.21% 900.0%
Acquisitions
YoY Change
Other Investing Activities -$40.00K $152.5K $40.00K
YoY Change -200.0% -125.1% -105.0%
Cash From Investing Activities -$240.0K -$572.5K -$60.00K
YoY Change 300.0% -32.57% -92.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 220.0K 972.0K 380.0K
YoY Change -42.11% -41.76% -66.67%
NET CHANGE
Cash From Operating Activities 10.00K -600.9K -220.0K
Cash From Investing Activities -240.0K -572.5K -60.00K
Cash From Financing Activities 220.0K 972.0K 380.0K
Net Change In Cash -10.00K -201.3K 100.0K
YoY Change -110.0% -834.86% -23.08%
FREE CASH FLOW
Cash From Operating Activities $10.00K -$600.9K -$220.0K
Capital Expenditures -$200.0K -$725.0K -$100.0K
Free Cash Flow $210.0K $124.1K -$120.0K
YoY Change -275.0% -122.53% -36.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
44657
CY2016Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
109825
CY2016Q3 acan Extinguishment Of Debt Reacquisition Price Of Debt Amount
ExtinguishmentOfDebtReacquisitionPriceOfDebtAmount
3333585
CY2016 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
109825
CY2016 acan Allocated Share Based Compensation Expense Difference Of Fair Market Value And Purchase Price
AllocatedShareBasedCompensationExpenseDifferenceOfFairMarketValueAndPurchasePrice
898800
CY2016Q3 acan Assets Heldforsale Not Part Of Disposal Group Noncurrent
AssetsHeldforsaleNotPartOfDisposalGroupNoncurrent
2250809
CY2015Q3 acan Assets Heldforsale Not Part Of Disposal Group Noncurrent
AssetsHeldforsaleNotPartOfDisposalGroupNoncurrent
0
CY2016Q3 acan Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
4341000
CY2016Q3 acan Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
6.19
CY2016 acan Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P2Y109D
CY2016 acan Class Of Warrant Or Right Granted During Period
ClassOfWarrantOrRightGrantedDuringPeriod
1750000
CY2016 acan Class Of Warrant Or Right Granted During Period Exercise Price
ClassOfWarrantOrRightGrantedDuringPeriodExercisePrice
2.14
CY2016 acan Class Of Warrant Or Right Granted Weighted Average Remaining Contract Term
ClassOfWarrantOrRightGrantedWeightedAverageRemainingContractTerm
P3Y292D
CY2014 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P3Y255D
CY2015 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P2Y255D
CY2016 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P2Y109D
CY2016 acan Debt Discount Premium
DebtDiscountPremium
35250
CY2015 acan Debt Discount Premium
DebtDiscountPremium
0
CY2016 acan Debt Discount Premium Due To Debt Modifications
DebtDiscountPremiumDueToDebtModifications
72651
CY2015 acan Debt Discount Premium Due To Debt Modifications
DebtDiscountPremiumDueToDebtModifications
0
CY2016Q3 acan Deferred Tax Assets Temporary Difference Gross
DeferredTaxAssetsTemporaryDifferenceGross
1165592
CY2015Q3 acan Deferred Tax Assets Temporary Difference Gross
DeferredTaxAssetsTemporaryDifferenceGross
1091670
CY2016Q3 acan Deferred Tax Assets Temporary Difference Net Operating Loss
DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss
1156331
CY2015Q3 acan Deferred Tax Assets Temporary Difference Net Operating Loss
DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss
916345
CY2016Q3 acan Deferred Tax Assets Temporary Difference Other
DeferredTaxAssetsTemporaryDifferenceOther
9261
CY2015Q3 acan Deferred Tax Assets Temporary Difference Other
DeferredTaxAssetsTemporaryDifferenceOther
175325
CY2016Q3 acan Deferred Tax Assets Temporary Difference Valuation Allowance
DeferredTaxAssetsTemporaryDifferenceValuationAllowance
1165592
CY2015Q3 acan Deferred Tax Assets Temporary Difference Valuation Allowance
DeferredTaxAssetsTemporaryDifferenceValuationAllowance
1091670
CY2016 acan Deferred Tax Assets Valuation Allowance Percent Offset
DeferredTaxAssetsValuationAllowancePercentOffset
1
CY2016Q3 acan Depoists On Land Noncurrent
DepoistsOnLandNoncurrent
925000
CY2015Q3 acan Depoists On Land Noncurrent
DepoistsOnLandNoncurrent
CY2016Q3 acan Deposits On Land Current
DepositsOnLandCurrent
0
CY2015Q3 acan Deposits On Land Current
DepositsOnLandCurrent
200000
CY2016 acan Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent
0.3706
CY2015 acan Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent
0.3706
CY2016 acan Effective Income Tax Rate Reconciliation Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent
-0.3706
CY2015 acan Effective Income Tax Rate Reconciliation Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent
-0.3706
CY2016Q3 acan Extinguishment Of Debt Net Amount
ExtinguishmentOfDebtNetAmount
2431646
CY2015Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
0
CY2016Q3 acan Notes And Loans Receivable Including Related Parties Net Current
NotesAndLoansReceivableIncludingRelatedPartiesNetCurrent
247378
CY2015Q3 acan Notes And Loans Receivable Including Related Parties Net Current
NotesAndLoansReceivableIncludingRelatedPartiesNetCurrent
0
CY2016Q3 acan Notes And Loans Receivable Including Related Parties Net Noncurrent
NotesAndLoansReceivableIncludingRelatedPartiesNetNoncurrent
898008
CY2015Q3 acan Notes And Loans Receivable Including Related Parties Net Noncurrent
NotesAndLoansReceivableIncludingRelatedPartiesNetNoncurrent
1251105
CY2016Q3 acan Notes And Loans Receivable Net
NotesAndLoansReceivableNet
1145386
CY2015Q3 acan Notes And Loans Receivable Net
NotesAndLoansReceivableNet
1251105
CY2016Q3 acan Notes Loans And Financing Receivable Net Related Parties Noncurrent
NotesLoansAndFinancingReceivableNetRelatedPartiesNoncurrent
117693
CY2015Q3 acan Notes Loans And Financing Receivable Net Related Parties Noncurrent
NotesLoansAndFinancingReceivableNetRelatedPartiesNoncurrent
0
CY2014Q1 acan Ownership Percentage Transfered
OwnershipPercentageTransfered
0.93
CY2016 acan Reclassification Of Debt To Related Party Debt
ReclassificationOfDebtToRelatedPartyDebt
521297
CY2015 acan Reclassification Of Debt To Related Party Debt
ReclassificationOfDebtToRelatedPartyDebt
0
CY2016Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
385380
CY2015Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
85298
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2581
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1458
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6512244
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5007497
CY2016 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
921288
CY2016Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
921288
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
131075
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
299602
CY2016Q3 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
469699
CY2015Q3 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
456470
CY2016 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
0
CY2015 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
27772
CY2016Q3 us-gaap Assets
Assets
4370366
CY2015Q3 us-gaap Assets
Assets
3994856
CY2016Q3 us-gaap Assets Current
AssetsCurrent
261649
CY2015Q3 us-gaap Assets Current
AssetsCurrent
2693895
CY2016Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0
CY2015Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
2250809
CY2016Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
14986
CY2015Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1153
CY2016 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
13833
CY2015 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1153
CY2016Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
26514
CY2015Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
40347
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201353
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173956
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-201329
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27397
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.92
CY2016Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2015Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2016 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
-60000
CY2015Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.92
CY2016Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.19
CY2014Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2591000
CY2015Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2591000
CY2016Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4341000
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
64400000
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17031000
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16631000
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17031000
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16631000
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
1703
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
1663
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.4pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Concentration of Credit Risks and Significant Customers</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, notes receivables, deposits, accounts receivables and notes receivable. We place our cash with high credit quality financial institutions. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September </div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> we had outstanding notes receivable of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$247,378</div> with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4900</div> Jackson, LLC, notes receivable of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$117,693</div> with Coastal Compassion Inc., and a note and a receivable in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,250,014</div> with WGP (exclusive of provision for doubtful accounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$469,699).</div> &nbsp; See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> in the Notes to the Financial Statements included as part of this report for a discussion of our provision for doubtful accounts for amounts owed from WGP.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September </div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> all of the Company&#x2019;s revenue was earned from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customer, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4900</div> Jackson, LLC. For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September </div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> revenue earned from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4900</div> Jackson, LLC was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$100,000,</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71%</div> of total revenues.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2016 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
0
CY2015 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
49849
CY2015 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
11740
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
60000
CY2016Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
431968
CY2015Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
404572
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14956
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2217
CY2016Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
2024297
CY2015Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1682849
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
CY2016Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
431968
CY2015Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
404572
CY2016Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2015Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2016Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
428536
CY2015Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
339597
CY2016Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3432
CY2015Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
64975
CY2016 us-gaap Operating Expenses
OperatingExpenses
1189421
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0306
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0306
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
37450
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P105D
CY2016 us-gaap Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
-725000
CY2015 us-gaap Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
-200000
CY2015 us-gaap Operating Expenses
OperatingExpenses
1947469
CY2015Q3 us-gaap Liabilities
Liabilities
2679863
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4370366
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3994856
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1737053
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
997014
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-1129421
CY2016Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-901939
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-991939
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
583739
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
835501
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
300082
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
59783
CY2016 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0
CY2015 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-16357
CY2016 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3454
CY2015 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
5975
CY2016 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-128744
CY2015 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-1021270
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
8924
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
CY2016 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
3211
CY2015 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
9957
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-24032
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
25050
CY2016 us-gaap Interest Expense
InterestExpense
162834
CY2015 us-gaap Interest Expense
InterestExpense
73198
CY2016 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
109825
CY2015 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
62342
CY2016 us-gaap Interest Paid
InterestPaid
151925
CY2015 us-gaap Interest Paid
InterestPaid
36357
CY2016Q3 us-gaap Interest Payable Current
InterestPayableCurrent
118749
CY2015Q3 us-gaap Interest Payable Current
InterestPayableCurrent
0
CY2016Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
2521
CY2015Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
5975
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
183255
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
213665
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
35145
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
34140
CY2016Q3 us-gaap Liabilities
Liabilities
3761350
CY2016Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
247378
CY2015Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0
CY2016Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
780315
CY2015Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1251105
CY2016Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1157997
CY2016 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
21312
CY2015 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
15172
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
972044
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1669006
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-632510
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-849075
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-540863
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-792534
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-2210764
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-1729344
CY2015Q3 us-gaap Notes Payable Current
NotesPayableCurrent
900000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-1807469
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
8393
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
7483
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
0
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
0
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
910
CY2016Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2551748
CY2015Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1395417
CY2016 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
0
CY2015 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
28542
CY2016Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
14927
CY2015Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
11716
CY2016 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1081343
CY2015 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
78125
CY2016 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
0
CY2015 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
100000
CY2016 us-gaap Payments For Loans
PaymentsForLoans
0
CY2015 us-gaap Payments For Loans
PaymentsForLoans
650000
CY2016 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2015 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
27772
CY2016 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0
CY2015 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
41500
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11726
CY2015Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
35758
CY2016 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
338927
CY2015 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
413695
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
724544
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
861006
CY2016 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
247500
CY2015 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1015000
CY2016 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-117693
CY2015 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0
CY2016 us-gaap Professional Fees
ProfessionalFees
571141
CY2015 us-gaap Professional Fees
ProfessionalFees
640326
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5276
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6399
CY2015 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
66932
CY2016 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
9173
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
609016
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
1314993
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2643553
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1314993
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13229
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
456470
CY2016 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2015 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
207000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5904931
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3694167
CY2016 us-gaap Revenues
Revenues
60000
CY2015 us-gaap Revenues
Revenues
140000
CY2016 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
60000
CY2015 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
140000
CY2016Q3 us-gaap Security Deposit
SecurityDeposit
3110
CY2015Q3 us-gaap Security Deposit
SecurityDeposit
3110
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y182D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y182D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y182D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y182D
CY2016Q3 us-gaap Stock Issued1
StockIssued1
408000
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
609016
CY2014Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
140249
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
366534
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
900000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
300000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
900000
CY2016 us-gaap Stock Issued1
StockIssued1
500000
CY2015 us-gaap Stock Issued1
StockIssued1
0
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
34250
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1364539
CY2016 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0
CY2015 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
34250
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1105000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1205000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1205000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.12
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.70
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.70
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1205000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
8.70
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1205000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
8.70
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4
CY2016Q3 us-gaap Share Price
SharePrice
0.75
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y
CY2016 us-gaap Taxes And Licenses
TaxesAndLicenses
0
CY2015 us-gaap Taxes And Licenses
TaxesAndLicenses
11222
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect &nbsp; the &nbsp; reported &nbsp; amounts of assets &nbsp; and &nbsp; liabilities &nbsp; and &nbsp; disclosure &nbsp; of contingent &nbsp; assets and &nbsp; liabilities at the date of the financial &nbsp; statements and the &nbsp; reported &nbsp; amounts of revenues &nbsp; and expenses &nbsp; during the &nbsp; reporting &nbsp; period. The more significant estimates and assumptions made by management are valuation of equity instruments, deferred tax asset valuation and allowance and collectability of long - lived assets. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions. &nbsp; &nbsp; See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> in the Notes to the Financial Statements included as part of this report for a discussion of our provision for doubtful accounts for amount amounts owed from WGP.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
27396
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
227029
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17031000
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16622507
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17031000
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16622507
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17031000
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16622507

Files In Submission

Name View Source Status
0001437749-17-000589-index-headers.html Edgar Link pending
0001437749-17-000589-index.html Edgar Link pending
0001437749-17-000589.txt Edgar Link pending
0001437749-17-000589-xbrl.zip Edgar Link pending
acan-20160930.xml Edgar Link completed
acan-20160930.xsd Edgar Link pending
acan-20160930_cal.xml Edgar Link unprocessable
acan-20160930_def.xml Edgar Link unprocessable
acan-20160930_lab.xml Edgar Link unprocessable
acan-20160930_pre.xml Edgar Link unprocessable
acan20160830_10k.htm Edgar Link pending
americann_audltr.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending